Economic spectroscopic evaluation of Cervical Cancer

描述（由申请人提供）： 宫颈癌是世界范围内女性第二常见的癌症类型，也是发展中国家女性癌症相关死亡的主要原因。早期发现和诊断可以挽救生命，减轻国家医疗保健系统的负担。我们已经建立了一个非侵入性的研究原型点的护理设备，以检测子宫颈的早期癌症状况。我们已经在一项多中心的全国性研究中测试了这个原型，该研究从600名女性那里收集了数据来训练我们的算法。通过与FDA的对话，我们现在已经制定了一个关键的试验方案来验证我们的算法。我们将在这项关键性研究中使用我们器械的预生产版本。预生产器械将是一种成本和尺寸减小、便携、坚固和用户友好的器械，预期与预期用于销售的器械相同，而不会产生进入生产阶段所需的工具成本。在此快速通道应用的第一阶段，我们将解决构建此预生产设备的高风险方面，并进行概念设计。在第二阶段，我们将最终完成该设计（组件级和系统集成），并构建10个器械副本以支持关键试验。我们还将完成必要的系统测试，并确定设备间/设备内的可变性。我们将以PMA提交所需的设计文件作为结论。

DESCRIPTION (provided by applicant): Cervical Cancer is the second most common type of cancer in women worldwide and the leading cause of cancer related mortality in women in developing countries. Early detection and diagnosis can saves lives and reduce the burden on the national healthcare system. We have built a non-invasive research-prototype point-of-care device to detect early cancerous conditions of the uterine cervix. We have tested this prototype in a multi-center national study accruing data from 600 women for training our algorithm. Through conversations with the FDA we now have in place a pivotal trial protocol for validating our algorithm. We will use a pre-production version of our device in this pivotal study. The pre-production device will be a cost and size reduced, portable, rugged and user-friendlier device and is intended to be identical to the device intended for sale without incurring the tooling costs necessary to enter the production phase. In Phase I of this fast track application we will address the high-risk aspects of building this pre-production device as well as arrive at a conceptual design. In Phase II we will finalize this design (both component level and systems integration) and build ten copies of the device to support the pivotal trial. We will also complete necessary systems tests and determine inter/intra device variability. We will conclude with the design documentation necessary for our PMA submission.